Last reviewed · How we verify

NCT06061055

Comparison of VentiBroncTM Anchor With Conventional Double-lumen Endobronchial Tube in Patients With High Risk of Malposition

Completed NA Last updated 12 December 2024
What this trial tests

NA trial testing Intubation with VentiBronc Anchor endobronchial double-lumen tube in Endotracheal Intubation in 154 participants. Completed in 26 November 2024.

Timeline
26 October 2023
Primary endpoint
26 November 2024
26 November 2024

Quick facts

Lead sponsorYonsei University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment154
Start date26 October 2023
Primary completion26 November 2024
Estimated completion26 November 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Yonsei University

Who can join

Adults 20 to 85, any sex, with Endotracheal Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators intend to compare the group using triple-cuffed endobronchial tube (VentiBroncTM Anchor) with the group using the conventional double-lumen endotracheal tube (Shiley®) in patients at high risk of malposition of the double-lumen endotracheal tube. The aim of this study is to determine if the use of VentiBroncTM Anchor increases the success rate of optimal double-lumen intubation to left main bronchus.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Novel Triple-Cuff versus Conventional Double-Cuff Double-Lumen Endobronchial Tube in Patients with Risk Factors for Tube Misdirection.
    Kim N, Oh YJ, Kim HJ, Lee K. · · 2025 · PMID 41287499 · DOI 10.3349/ymj.2025.0060

Verify or expand the search:

Other recruiting trials for Endotracheal Intubation

Currently open trials in the same condition.

Other Yonsei University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06061055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing